Migraines and ovarian hyperstimulation syndrome: a dopamine connection

被引：10
|
作者：
Rollene, Nanette L. [1 ]
Khan, Zaraq [1 ]
Schroeder, Darrell R. [2 ]
Cutrer, F. Michael [3 ]
Coddington, Charles C. [1 ]
机构：
[1] Mayo Clin, Div Reprod Endocrinol, Rochester, MN 55905 USA
[2] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA
来源：
FERTILITY AND STERILITY | 2011年 / 95卷 / 01期
关键词：
Ovarian hyperstimulation syndrome; migraines; dopamine; PCOS; multiple gestation; risk factors; prediction; ENDOTHELIAL GROWTH-FACTOR; IN-VITRO FERTILIZATION; EPIDEMIOLOGY; WOMEN;
D O I：
10.1016/j.fertnstert.2010.08.041
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
This case-control study shows a strong association between migraine history and development of ovarian hyperstimulation syndrome (OHSS). We hypothesize there may be a similar gene variant that predisposes women to both migraines and OHSS and identification will lead to optimal therapy, not only for OHSS, but also for women who suffer from migraines. (Fertil Steril (R) 2011;95:417-9. (C) 2011 by American Society for Reproductive Medicine.)
引用
收藏
页码：417 / 419
页数：3
相关论文
共 50 条
  • [1] Migraines as a Predictor for Ovarian Hyperstimulation Syndrome: The Dopamine Connection.
    Rollene, Nanette L.
    Khan, Zaraq
    Amols, Mark H.
    Gada, Ravi P.
    Jensen, Jani R.
    Coddington, Charles C.
    [J]. REPRODUCTIVE SCIENCES, 2010, 17 (03) : 264A - 265A
  • [2] Dopamine agonists for preventing ovarian hyperstimulation syndrome
    Tang, Huilin
    Mourad, Selma
    Zhai, Suo-Di
    Hart, Roger J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (11):
  • [3] Dopamine agonists in prevention of ovarian hyperstimulation syndrome
    Kasum, Miro
    Vrcic, Hrvoje
    Stanic, Patrik
    Jezek, Davor
    Oreskovic, Slavko
    Beketic-Oreskovic, Lidija
    Pekez, Marijeta
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (12) : 845 - 849
  • [4] DOPAMINE TREATMENT FOR SEVERE OVARIAN HYPERSTIMULATION SYNDROME
    FERRARETTI, AP
    GIANAROLI, L
    DIOTALLEVI, L
    FESTI, C
    TROUNSON, A
    [J]. HUMAN REPRODUCTION, 1992, 7 (02) : 180 - 183
  • [5] Dopamine agonists for preventing ovarian hyperstimulation syndrome
    Tang, H.
    Mourad, S. M.
    Wang, A.
    Zhai, S. D.
    Hart, R. J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (04):
  • [6] Dopamine agonist bromocriptine for the prevention of ovarian hyperstimulation syndrome
    Spitzer, Dietmar
    Wogatzky, Johannes
    Murtinger, Maximilian
    Zech, Mathias H.
    Haidbauer, Robert
    Zech, Nicolas H.
    [J]. FERTILITY AND STERILITY, 2011, 95 (08) : 2742 - U405
  • [7] OVARIAN HYPERSTIMULATION SYNDROME FOLLOWING DOPAMINE RECEPTOR AGONIST THERAPY
    LEWIS, L
    HOFREITER, B
    MIZERA, A
    ALLEN, J
    [J]. NEUROENDOCRINOLOGY LETTERS, 1983, 5 (03) : 180 - 180
  • [8] Ovarian hyperstimulation syndrome ovarian hyperstimulation syndrome - A cost analysis
    Wagner, S.
    Emran, J.
    Beckmann, M. W.
    Binder, H.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2007, 67 (03) : 261 - 264
  • [9] How to avoid ovarian hyperstimulation syndrome: a new indication for dopamine agonists
    Garcia-Velasco, Juan A.
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2009, 18 : S71 - S75
  • [10] Treatment for ovarian hyperstimulation syndrome using an oral dopamine prodrug, docarpamine
    Tsunoda, T
    Shibahara, H
    Hirano, Y
    Suzuki, T
    Fujiwara, H
    Takamizawa, S
    Ogawa, S
    Motoyama, M
    Suzuki, M
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2003, 17 (04) : 281 - 286
12345